Clinical Trial Update: A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 clinical trial to determine a suitable dose of ASP4396 in adults with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ASP4396

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING